Nalaganje...
HIV-1 vaccine immunogen design strategies
An effective human immunodeficiency virus type 1 (HIV-1) vaccine is expected to have the greatest impact on HIV-1 spread and remains a global scientific priority. Only one candidate vaccine has significantly reduced HIV-1 acquisition, yet at a limited efficacy of 31%, and none have delayed disease p...
Shranjeno v:
| izdano v: | Virol J |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4318220/ https://ncbi.nlm.nih.gov/pubmed/25616599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-014-0221-0 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|